Multiple
Sclerosis (MS) Drugs
|
|
|
Rebif ®
|
(interferon beta-1a)
|
| |
MS Drugs - Rebif ® Efficacy
|
(Effectiveness of Rebif ®)
|
| |
How effective is Rebif ®?
|
| |
|
% of patients exacerbation free
at 2 years
|
|
Placebo
|
Rebif ®
|
Rebif ® |
|
22mcg
|
44mcg
|
|
15 %
|
25 %
|
32 %
|
|
| |
| |
Number of exacerbations in Subset
(people who completed full 2 years) completing 2 years of Rebif
®
|
|
Average exacerbations per patient
over 2 years
|
|
Placebo
|
Rebif ®
|
Rebif ® |
|
22mcg
|
44mcg
|
|
2.56 |
1.82
|
1.73 |
|
| |
| Ref: Rebif ® prescribing information |
|
|
| Reviewed July 2004 |
|
|
